Relationships between pathological factors and long-term outcomes in patients enrolled in two prospective randomized controlled trials comparing the efficacy of oral tegafur–uracil with CMF (N·SAS-BC 01 trial and CUBC trial)

PURPOSE: To evaluate the efficacies of cyclophosphamide, methotrexate, and fluorouracil (CMF) and tegafur–uracil (UFT) as adjuvant therapy in patients with resected stage I–IIIA breast cancer by immunohistochemistry (IHC)-based subtype and to determine the relationships between clinicopathological f...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohno, Shinji, Saji, Shigehira, Masuda, Norikazu, Tsuda, Hitoshi, Akiyama, Futoshi, Kurosumi, Masafumi, Shimomura, Akihiko, Sato, Nobuaki, Takao, Shintaro, Ohsumi, Shozo, Tokuda, Yutaka, Inaji, Hideo, Watanabe, Toru, Ohashi, Yasuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940338/
https://www.ncbi.nlm.nih.gov/pubmed/33259001
http://dx.doi.org/10.1007/s10549-020-06018-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940338/
https://www.ncbi.nlm.nih.gov/pubmed/33259001
http://dx.doi.org/10.1007/s10549-020-06018-1

Ejemplares similares